California Legislative Success Makes Screenings and Treatment More Accessible

Komen-california

Susan G. Komen® is the voice for the more than 3.1 million breast cancer survivors and those who love them, working to ensure that the fight against breast cancer is a priority among policymakers in Washington, D.C., and every Capitol across the country.  Komen has a history of more than 30 years in public policy and advocacy. In order to achieve our mission, we believe that scientific progress must be complemented by sound legislative and regulatory advocacy. Through government action, broad, systemic, lasting change can be made in the fight against breast cancer. This means that Komen—as a patient advocacy organization with first-hand knowledge of how breast cancer touches local communities—must engage policymakers and government as partners in our efforts to end breast cancer forever.

As the United States Congress and state legislatures convene this year, Komen is pleased to announce its 2017 Advocacy Priorities.  These issues will serve as the focus of our advocacy work in the coming year.  They are:

  • Support expanded federal funding for all biomedical research, especially breast cancer research at the National Institutes of Health (NIH) and Department of Defense (DOD);
  • Support state and federal funding for the Centers for Disease Control and Prevention’s (CDC) National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and support policies to modernize NBCCEDP state programs to expand eligibility and provide breast cancer screening and diagnostic services for additional populations;
  • Advocate for policies to improve insurance coverage of breast cancer treatments and screening, specifically pertaining to increased access to drug therapies and limiting out-of-pocket costs for diagnostic mammography; and
  • Evaluate state and federal policies to reduce to increase awareness, education and access to clinical trials for all patient populations.

Additionally, as we transition to a new administration and the 115th Congress, we must ensure that our policymakers understand the needs of breast cancer patients and the importance of preserving critical patient protections and continuous insurance coverage.

To advance our efforts, we are building a library of stories that reiterate the importance of our advocacy priorities and we need your help!  We are looking for stories that address:

  • Impact of improved insurance coverage
  • Importance of early detection and education
  • Access and coverage of breast screenings
  • Access and coverage of clinical trials
  • Access and coverage of drug therapies
  • Impact of cancer research

If you have been impacted by any of these issues, please submit your story and contact information to policy@komen.org.